Bolstered by investments made in Asia over the past year, Qiagen this week said that sales in the region grew 30 percent year over year to roughly $9.1 million for the second quarter.
 
The firm made several moves last year to expand its footprint in Asia, including acquiring Tianwei Times and Shenzhen PG Biotech, and opening an office in Shanghai.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.